title: Impact of injections during diagnostic coronary arteriography on coronary patency in the setting of acute myocardial infarction from the TIMI trials. Thrombolysis In Myocardial Infarction.
abstract: The mechanical force of injection at 90 minutes opens 13.4% of occluded arteries, but overall, only 2.4% of all culprit arteries (already open and occluded combined) are opened. Thus, although some arteries are opened by the force of hand injection, the frequency of mechanical opening among all arteries is low, and hand injections appear to alter current 80% patency rates by approximately 2.5%.
authors: Department of Medicine, University of California Medical Center, San Francisco 94118, USA.
authors: C M
authors: CM
authors: Gibson
authors: M
authors: M
authors: Anshelevich
authors: S
authors: S
authors: Murphy
authors: L
authors: L
authors: Luu
authors: C
authors: C
authors: Hynes
authors: J
authors: J
authors: Kliris
authors: S
authors: S
authors: Kermgard
authors: M H
authors: MH
authors: Otten
authors: E M
authors: EM
authors: Antman
authors: C P
authors: CP
authors: Cannon
authors: E
authors: E
authors: Braunwald
mesh_terms: D000077284:Abciximab; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use; D003287:Contrast Media; D017023:Coronary Angiography; D003326:Coronary Circulation / Q000502:physiology; D003331:Coronary Vessels / Q000473:pathology / Q000503:physiopathology*; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000008:administration & dosage / Q000627:therapeutic use; D007269:Injections, Intra-Arterial; D009203:Myocardial Infarction / Q000000981:diagnostic imaging* / Q000188:drug therapy / Q000503:physiopathology; D016017:Odds Ratio; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors; D011446:Prospective Studies; D012212:Rheology; D013314:Stress, Mechanical; D000077785:Tenecteplase; D015912:Thrombolytic Therapy; D013997:Time Factors; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage / Q000627:therapeutic use; D014654:Vascular Patency / Q000502:physiology*
chemical_list: D000911:Antibodies, Monoclonal; D003287:Contrast Media; D005343:Fibrinolytic Agents; D007140:Immunoglobulin Fab Fragments; D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D010959:Tissue Plasminogen Activator; D000077785:Tenecteplase; D000077284:Abciximab